Performance Equivalence of Rainbow Acoustic Monitoring (RAM) Small Sensor and RAM Revision D Sensor
1 other identifier
interventional
29
1 country
1
Brief Summary
The purpose of this study was to conduct a side by side comparison of the accuracy of respiratory rate (RR) between our investigational Rainbow Acoustic Monitoring (RAM) small sensor and the FDA-cleared RAM Revision D sensor in healthy volunteers under controlled conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Dec 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 29, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 29, 2015
CompletedFirst Submitted
Initial submission to the registry
April 14, 2017
CompletedFirst Posted
Study publicly available on registry
April 20, 2017
CompletedOctober 22, 2018
October 1, 2018
11 months
April 14, 2017
October 17, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Performance comparison of RAM sensors by ARMS calculation
Performance comparison was determined by comparing the noninvasive respiration rate measurement of the RAM sensors and calculating the arithmetic root mean square (Arms) error value.
50 minutes
Study Arms (1)
Test group
EXPERIMENTALThe subjects will be enrolled in the test group and will simultaneously receive both RAM sensors.
Interventions
Eligibility Criteria
You may qualify if:
- Male or female
- Physical status of ASA I or II
- Must be able to read and communicate in English
- Has signed written informed consent
You may not qualify if:
- ASA physical status of III, IV, and V
- Subject has any medical condition which in the judgement of the investigator, renders them inappropriate for participating in this study
- Inability to tolerate sitting still or minimal movement for at least 30 minutes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Masimo Clinical Lab
Irvine, California, 92618, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2017
First Posted
April 20, 2017
Study Start
December 2, 2014
Primary Completion
October 29, 2015
Study Completion
October 29, 2015
Last Updated
October 22, 2018
Record last verified: 2018-10